It also runs the other way. A result can read lower than your actual glucose exposure. Either way, a reading that does not match your glucose readings or your clinical picture is a reason to test further, not a reason to guess.
It measures the share of hemoglobin inside your red blood cells that has glucose attached to it, reported as a percentage. Because glucose attaches slowly and stays attached for the life of the cell, Hemoglobin A1C gives a rolling picture of glucose exposure over roughly the previous two to three months rather than a snapshot of this morning. It runs on a small blood sample, needs no fasting and can be drawn at any time of day.
The biomarker page covers how the test is run, what the standard ranges are and how to read a single result. This guide picks up the harder question, which is what can lift that percentage when glucose itself is not the explanation, and how to tell the two situations apart.
A result is flagged as high when it sits above the top of the standard laboratory reference range, which most labs set at 5.7 %. Labs commonly report 5.7 to 6.4 % as the intermediate band often called prediabetes, and 6.5 % or above as the band that falls in the diabetes range, with interpretation and confirmatory testing left to a clinician.
| Measure | Range | How to read it |
|---|---|---|
| Typical lab reference range | 4 to 5.7 % | The band most labs report as normal |
| FitScript optimal range | 4.6 to 5.3 % | FitScript's optimization target |
Reference ranges vary by lab, age and sex, and the method a lab uses can shift a result slightly. FitScript's optimal range is an optimization target, not a diagnostic cut-off. A number above the optimal band but inside the standard range is not a diagnosis of anything. It is a prompt to look at the rest of the metabolic picture, and at whether the number is even a faithful reflection of your glucose.
Yes, and the mismatch is common enough to have a name, discordance. Research suggests that HbA1c and directly measured glycemia disagree in a meaningful proportion of people, so two individuals with similar average glucose can land on different percentages 1.
The reason is structural. The test does not measure glucose. It measures the product of glucose and time spent inside a red blood cell. Change the red cell side of that equation, or change how the lab detects the glycated fraction, and the percentage moves without anything happening to your blood sugar.
Continuous glucose monitoring has made this easier to see outside of diabetes. Research suggests that, in people without diabetes, the glucose management indicator derived from sensor data frequently differs from the laboratory HbA1c in the same person 2. In practice, that means a single elevated percentage is a question rather than an answer. The useful next move is to ask whether an independent measure of glucose agrees with it, and whether anything about your red blood cells could be inflating the reading.
Because glycation accumulates with time, cells that live longer collect more glucose. Research suggests that factors beyond average glucose, including variation in red blood cell survival and in how readily hemoglobin becomes glycated, influence the HbA1c value a person produces 3.
Picture two people with identical average glucose. In the first, red cells circulate for the typical span before being cleared. In the second, cells survive longer, so each one spends extra weeks bathing in the same glucose and picks up more of it. The second person's sample contains a higher glycated fraction and the lab reports a higher percentage, even though nothing is different about their metabolism.
Anything that lengthens average red cell survival gives glucose more time to attach and nudges the percentage up, while anything that shortens survival does the opposite 4. This single mechanism explains most of the non-glucose causes in the sections that follow. It is also why clinicians pay attention to a complete blood count when a result looks out of step with the rest of someone's picture.
Yes, low iron is one of the better recognised non-glucose causes of an elevated reading. Research suggests that iron deficiency anemia is associated with higher HbA1c values, and that the values tend to fall once iron status is restored 5.
This matters because iron deficiency is common, often quiet and frequently undetected in people who feel broadly well, particularly in menstruating women, endurance athletes, regular blood donors and people eating little heme iron. Someone in that group can arrive at a routine panel with a percentage sitting at the top of the standard range, no symptoms of high blood sugar, and a fasting glucose that looks unremarkable.
The practical sequence is simple. If a result lands above the optimal band and nobody has checked iron, a full blood count with ferritin and iron studies gives context that the percentage alone cannot. A clinician can then judge whether the reading reflects glucose, iron status, or both at once. Iron deficiency itself has causes worth identifying, so a low ferritin is a finding to follow up rather than a loose end to tidy away.
Reduced kidney function makes the result harder to interpret, and it can push the number in either direction. Research suggests that chronic kidney disease alters HbA1c through several routes at once, including shortened red cell survival, anemia and the altered chemistry of the uremic state 6.
That pulls two ways. Shortened red cell survival tends to lower the percentage, while other changes in people with advanced kidney disease can raise it. The net effect in one person is not predictable from the number alone, which is exactly why clinicians stop treating the percentage as a standalone readout when kidney function is reduced.
For anyone with a known kidney issue, or with a creatinine and estimated filtration rate that have drifted, the sensible approach is to read the percentage alongside kidney markers and a blood count rather than in isolation. Direct glucose measurement, whether fasting, post-meal or sensor based, carries more weight in that setting. None of this means an abnormal result should be set aside. It means the interpretation belongs to a clinician who can see the kidney numbers next to it.
Yes. Hemoglobin variants, which are inherited differences in the structure of the hemoglobin molecule, can interfere with the measurement itself. Research suggests that the effect of a variant on a reported HbA1c depends on which analytical method the laboratory uses, with different platforms affected to different degrees 7.
Two separate things can happen. A variant can genuinely change red cell survival, which alters the true glycated fraction. Or a variant can confuse the assay, so the instrument reports a figure that does not represent the real glycated fraction at all. The second is a measurement artifact and no amount of dietary change will move it.
Variants are more frequent in some ancestral backgrounds than others, and many carriers have no symptoms and have never been tested. A clue worth noticing is a result that stays stubbornly high or stubbornly low across repeat draws while fasting glucose, post-meal glucose and clinical picture all say something different. Laboratories can often identify interference and switch to a different method or a different marker. That decision sits with the clinician and the lab.
It can, and it matters most when something unusual is present in the sample. Because methods detect the glycated fraction in different ways, the same blood can produce slightly different figures depending on the platform, and the gap widens when a hemoglobin variant is involved 7.
For most people, assay differences are small and clinically unimportant. They start to matter in three situations. First, when a result sits right at a decision threshold, so a small analytical shift changes which band it falls into. Second, when a variant or other interfering substance is present. Third, when someone is comparing results drawn at different labs over time and reading a change that reflects the method rather than their physiology.
Research suggests that recognising these pitfalls, and knowing when to reach for an alternative measure of glycemic exposure, is part of using the test well 4. The practical habit is to track the marker at the same laboratory where you can, and to compare serial results from one method rather than stitching together numbers from several.
Several clinical states sit outside the simple glucose story. Research suggests that HbA1c should be interpreted cautiously in a range of settings, including hemoglobin disorders, various anemias, pregnancy and dialysis, where the usual relationship between the percentage and average glucose no longer holds reliably 8.
Recent blood loss, a recent transfusion and conditions that break down red cells early all change the age mix of the circulating red cell population, and with it the glycated fraction the lab measures. Pregnancy changes red cell turnover and plasma volume, which is one reason pregnancy glucose assessment usually leans on direct glucose testing rather than this marker.
The common thread is worth holding onto. None of these situations make the test worthless. They make it one input among several. When one of them applies, the observation is that the percentage is elevated, the inference is that red cell biology or the assay may be contributing, and the next step is a conversation with a clinician about which additional test would settle the question.
Yes, and a falsely reassuring result is arguably the more consequential error. Anything that shortens the average life of a red blood cell removes cells from circulation before they have accumulated their full share of glucose, so the lab reports a lower percentage than your glucose exposure deserves 4.
Conditions that break down red cells early, recent significant blood loss, and some of the changes that accompany advanced kidney disease can all work in this direction 6. Research suggests that these situations are among those where the result should not be read at face value 8.
The practical implication is this. A comfortable percentage in someone with symptoms suggestive of high blood sugar, a strong family history, or fasting glucose readings that keep creeping up, does not close the file. Direct glucose measurement is the tiebreaker. A low or mid-range number is reassuring only when nothing in the blood count or clinical picture suggests the red cell side of the equation has been altered.
It means one of the two is telling you something the other cannot, and the gap itself is informative. Research suggests that discordance between HbA1c and measured glycemia is a recognised phenomenon rather than a sign that the lab made an error 1, and that it also appears in people without diabetes when sensor-derived glucose is compared with the laboratory value 2.
Work through it in order. The observation is a specific gap, for example a percentage above 5.7 % alongside fasting glucose in the normal range and unremarkable post-meal readings. The possible meanings include longer than average red cell survival, low iron, reduced kidney function, a hemoglobin variant, assay interference, or genuine glucose elevation that fasting values simply are not catching because the rises happen after meals.
The next step is not to pick a favourite theory. It is to add the two or three tests that separate them, which is where a blood count, iron studies, kidney markers and a direct measure of glucose earn their place. Research suggests that measures beyond HbA1c are useful precisely when the percentage and the clinical picture do not line up 3.
The most useful additions fall into three groups, a direct look at glucose, a look at red blood cells, and a look at kidney function. Together they usually explain the gap.
When the marker is judged unreliable, alternative measures of glycemic exposure such as fructosamine and glycated albumin reflect a shorter window and do not depend on red cell lifespan in the same way 4, and research suggests these alternatives have a role when HbA1c alone is not enough 3. FitScript's membership includes 150+ biomarkers tested per year, and Atlas, its AI health advisor, reads each marker against the others rather than in isolation. This article is educational and is not medical advice.
Yes, and this is the most common outcome of all. A percentage in the 5.7 to 6.4 % band often reflects genuine glucose elevation that has not reached the diabetes range, a state usually described as prediabetes or impaired glucose regulation. It is a real finding about metabolic health, and it is not a diagnosis of diabetes.
Insulin resistance typically develops long before fasting glucose moves. Insulin output rises to hold glucose steady, post-meal excursions grow larger and last longer, and the percentage drifts upward in small steps across years. That pattern is why a result just above the optimal band is worth attention even though nothing on the report is flagged in red.
It is also why fasting insulin, triglycerides, HDL cholesterol, waist measurement and liver markers are informative alongside the glucose numbers. Taken together, they distinguish early insulin resistance from a reading inflated by red cell biology. A single value never establishes a diagnosis in either direction. A clinician interprets the pattern, usually across more than one draw, before anything is called by name.
When the elevation really does reflect glucose, the levers are the ordinary ones, and they are the reason the distinction in this article matters so much. There is no point reorganising your diet around a number that is high because of low iron or an assay quirk.
Clinicians usually start by looking at the amount and type of carbohydrate across the day, the gap between meals, body composition and visceral fat, the amount and timing of daily movement, sleep duration and quality, and alcohol intake. Resistance training and walking after meals both influence how muscle handles a glucose load, and these are the habits most often reviewed first because they are available to nearly everyone.
Some people also need medical care beyond lifestyle change. Any prescription option is evaluated by a licensed provider who reviews your history, your full laboratory picture and your other medications before deciding whether it is appropriate. Because the marker reflects two to three months of exposure, it responds slowly, so retesting a few weeks after a change usually shows very little. Give it a full cycle.
Bring any result above the standard reference range to a clinician, and bring it promptly if it sits in or near the diabetes range, if you have symptoms such as unusual thirst, frequent urination, blurred vision or unexplained weight loss, or if you are pregnant or planning a pregnancy.
Also raise it when the number and the rest of your picture do not agree. A percentage that stays high while your glucose readings stay normal, a percentage that looks fine while your fasting glucose keeps climbing, a large jump between two draws with no change in habits, or a known kidney condition, anemia or family history of a hemoglobin variant are all reasons to ask for a wider workup rather than a repeat of the same single test.
Discuss your results and any treatment with a clinician or licensed provider, who can order the follow-up tests, interpret them against your history and decide what comes next. Never set aside an out of range result on the assumption that something else explains it. The point of understanding these alternative causes is to ask better questions, not to self-interpret your way past an abnormal number.
For more context on where the standard thresholds sit and what a borderline reading means in practice, read is hemoglobin a1c 5 7 bad, and if your elevation does reflect glucose, how to lower your hemoglobin a1c covers the daily habits clinicians review first.
Yes. The test reflects both average glucose and how long your red blood cells survive, so changes in red cell biology or in the laboratory method can lift the percentage while your day to day blood sugar stays normal. A clinician decides what a specific result means for you.
Low iron, reduced kidney function, inherited hemoglobin variants, recent blood loss or transfusion, pregnancy and interference with the laboratory assay are the usual candidates. Each one changes either how long red cells live or how accurately the instrument detects the glycated fraction.
It can. Iron deficiency changes red blood cell turnover in a way that tends to lift the reported percentage, and the value often settles once iron status improves. If nobody has checked your ferritin and blood count alongside the result, that is a reasonable request to make.
No. Diagnosis is made by a clinician, usually after confirming an abnormal value on a repeat sample or alongside a direct glucose measurement. A single percentage, read without context, is a prompt for further testing rather than a conclusion.
Fasting glucose, a glucose tolerance test, continuous glucose monitoring, fructosamine and glycated albumin all give information that does not depend on red cell lifespan in the same way. Your clinician chooses which alternative fits your situation.
No. Because it reflects glucose exposure over roughly the previous two to three months, it can be drawn at any time of day, with or without food. Other markers often ordered at the same visit, such as fasting glucose and insulin, usually do require fasting.
A few stressful days or a brief illness will not move it much, because the value averages months of exposure. Sustained stress, disrupted sleep or prolonged illness that keeps glucose elevated for weeks can nudge it upward over time.
Take it to a clinician rather than acting on it alone. Useful next steps usually include a repeat test, a direct glucose measurement, a complete blood count with iron studies and kidney markers, so you can tell a genuine glucose elevation from a reading shifted by something else.